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Abstract
Migraine is triggered by poor air quality and odors through unknown mechanisms. Activation of the trigeminovascular
pathway by environmental irritants may occur via activation of transient receptor potential ankyrin 1 (TRPA1) receptors on
nasal trigeminal neurons, but how that results in peripheral and central sensitization is unclear. The anatomy of the trigeminal
ganglion suggests that noxious nasal stimuli are not being transduced to the meninges by axon reflex but likely through
intraganglionic transmission. Consistent with this concept, we injected calcitonin gene-related peptide, adenosine triphos-
phate, or glutamate receptor antagonists or a gap junction channel blocker directly and exclusively into the trigeminal
ganglion and blocked meningeal blood flow changes in response to acute nasal TRP agonists. Previously, we observed chronic
sensitization of the trigeminovascular pathway after acrolein exposure, a known TRPA1 receptor agonist. To explore the
mechanism of this sensitization, we utilized laser dissection microscopy to separately harvest nasal and meningeal trigeminal
neuron populations in the absence or presence of acrolein exposure. mRNA levels of neurotransmitters important in
migraine were then determined by reverse transcription polymerase chain reaction. TRPA1 message levels were significantly
increased in meningeal cell populations following acrolein exposure compared to room air exposure. This was specific to
TRPA1 message in meningeal cell populations as changes were not observed in either nasal trigeminal cell populations or
dorsal root ganglion populations. Taken together, these data suggest an important role for intraganglionic transmission in
acute activation of the trigeminovascular pathway. It also supports a role for upregulation of TRPA1 receptors in peripheral
sensitization and a possible mechanism for chronification of migraine after environmental irritant exposure.
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Introduction
Air pollution and odors are known triggers of migraine,
and poor air quality is correlated with an increase in
emergency room visits for headache symptoms.
Although evidence for an association between odor
and primary headache, especially migraine exists, the
exact mechanism of action of odors as migraine triggers
is not known. Migraine is a complex neurologic disorder
with up to 25% of patients reporting heightened sensi-
tivity to odors, and up to 50% reporting that odors may
trigger acute migraine attacks. Studies have shown that
inhalation of certain odors or exposure to a variety of
chemicals can cause severe headache attacks through
stimulation of transient receptor potential ankyrin 1
(TRPA1) receptors.1 TRPA1 receptors are excitatory
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ion channels expressed in trigeminal sensory neurons
which innervate the nasal and respiratory epithelium,
dura, and other parts of the trigeminovascular pathway
and have been linked to migraine.
Although inhaled odors and chemicals may trigger
migraine symptoms, the mechanism linking activation
of nasal TRPA1 receptors to peripheral and central
sensitization of trigeminal pain pathways remain
unknown. We propose that intraganglionic transmission
within the trigeminal ganglia (TG) mediates communi-
cation between populations of neurons innervating dif-
ferent structures of the trigeminovascular pathway. This
type of communication has been described in several
ganglia and has been referred to as cross-excitation.2–7
Excitation of ganglion neurons leads to increased action
potentials in neighboring neurons that are believed to be
dependent on the release of diffusible chemical media-
tors. Cross-excitation of neuron populations may be
responsible for chronic pain or sensitization.4 Within
the TG, cell bodies of afferent sensory neurons from
the nasal epithelium, dural blood vessels, and periorbital
skin are in proximity to each other,8–10 which could
enable signals from the nasal epithelium to be relayed
to neurons targeting other structures. A number of
chemical mediators in the TG, including glutamate,11
adenosine triphosphate (ATP),12,13 and calcitonin
gene-related peptide (CGRP),14 may act as signaling
molecules between the neurons. Gap junctions15,16 and
satellite glia17 also appear to be important in chronic
trigeminal pain. Herein, we examine the functional role
of these mediators and components in the activation
of the trigeminovascular pathway by environmental irri-
tants. Specifically, we examine the effect of CGRP on
the excitability of sensory neurons and describe the out-
come of blocking specific neurotransmitters in the
trigeminal ganglion.
We hypothesize that air pollution-induced headache
is mediated by stimulation of TRPA1 receptors and sub-
sequent activation of the trigeminovascular pathway.
As evidence, we previously reported that acute nasal
administration of environmental irritants increased men-
ingeal blood flow in a TRPA1- and CGRP-dependent
manner.8,18 Furthermore, inhalation pre-exposure to
subacute doses of the environmental irritant and
TRPA1 channel agonist acrolein sensitized blood flow
and behavioral responses and induced periorbital allo-
dynia, effects which are long-lasting.19,20 This suggests
that trigeminovascular sensitization involving TRPA1
channel activation is a possible means for enhanced
headache susceptibility after chemical exposure.
Although we observed no changes in TRPA1 receptor
mRNA from whole TG following chronic inhalation of
acrolein,20 it is possible that specific relevant subpopula-
tions of TG neurons might demonstrate changes. To
further examine the role of TRPA1 and other signaling
molecules in acrolein-induced sensitization, we com-
bined retrograde labeling, laser dissection microscopy
and quantitative PCR (qPCR) to identify and compare
changes in message expression in selected nasal versus
dural afferent neuronal populations from the TG. Our
results demonstrate that TRPA1 mRNA levels are
increased only in dural, but not nasal, projecting neu-
rons in TG following acrolein exposure and suggest a
possible role for these receptors in environmental irritant
induced trigeminovascular sensitization.
Methods
All animal procedures were approved by the
Institutional Animal Care and Use Committee at the
Indiana University School of Medicine and followed
the ethical guidelines of International Association for
the Study of Pain.21 Experiments were performed on
225 adult male (170–250 g) Sprague–Dawley rats
(Envigo, IN). Rats were housed in pairs in solid
bottom cages with hardwood chip bedding with a stan-
dard 12 h light and dark cycle with free access to food
and water. Animals were randomly assigned to experi-
mental groups and weighed daily during treatment. No
adverse effects of treatment were observed. All results
are reported according to Animal Research: Reporting
of In Vivo Experiments (ARRIVE) guidelines.
Dorsal root ganglion neuron dissociation and culture
Dorsal root ganglion (DRG) neurons from adult rats
(150–180 g) were dissociated and cultured as described
previously.22 In brief, DRGs were isolated from lumbar
segments of spinal cords and dissociated by a combina-
tion treatment with a dispase/collagenase cocktail and
mechanical disruption through a series of fire-polished
glass pipettes with a decreasing inner tip diameter. The
resulting suspension of single cells was plated on to poly-
D-lysine-coated 15-mm glass coverslips (one thickness)
for electrophysiology and imaging, or poly-D-lysine and
laminin-coated wells or dishes for Western blotting. In
all cases, cells were maintained in Dulbecco’s modified
Eagle’s medium (Gibco, Invitrogen, Grand Island, NY)
supplemented with 10% fetal bovine serum (Hyclone,
Logan, UT) and 100 units/ml penicillin and 100 mg/ml
streptomycin for 16 to 24 h at 37C under 5% CO2.
Electrophysiology
Somatic whole-cell membrane potentials were measured
using patch electrodes in the whole-cell configuration with
an Axopatch 200 amplifier. Data were collected and ana-
lyzed using Clampex7 software, and graphs and statistical
tests were performed in SigmaPlot. Patch pipettes were
constructed from N51A glass and polished on a home-
made microforge at 600 magnification. All experiments
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were performed at room temperature (21C–23C). The
standard external solution contained (in mM): 145 NaCl,
5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose. The
internal solution in the patch electrode contained
(in mM): 130 potassium aspartate, 20 KCl, 1 EGTA,
1 MgCl2, 10 HEPES, and 10 glucose. All solutions were
adjusted to a pH of 7.4 and an osmolarity of 305 mOsm
for the internal solution and 297 for the external.
Two different current clamp protocols were
employed, a ramp protocol, and a continuous recording
protocol. For the ramp protocol, ramp currents of 400–
1800 ms duration, beginning at 0.1 nA and ending at
2.1 nA were injected into the cells, and the resulting
action potentials were recorded. The slope of the ramp
was increased with each sweep. The gap-free protocol
was used to determine the effect of CGRP application
to the resting potential without current injection.
Drugs were applied locally onto the cells by gravity
using a small diameter (250 mm) quartz capillary.
Capsaicin stock (1 mM, Sigma) was made in ethanol,
diluted to 0.1 1 mM with SESþ 0.05 – 0.1% BSA, and
applied. CGRP (Tocris) stocks (100 mM) were made in
SESþ 0.05 0.1% BSA and diluted to 100 300 nM.
The CGRP receptor antagonist, CGRP8-37, was made at
300 nM made in SESþ 0.05 0.1% BSA. When the
antagonist was applied, it was combined with the
CGRP peptide at 100 nM prior to bath application.
Vehicle controls (ethanol 0.05%þ 0.1% BSA) were also
applied to the cells.
Retrograde labeling
Labeling of the trigeminal innervation of the middle
cerebral artery (MCA) followed the procedure of
O’Connor and van der Kooy.9 Briefly, male rats were
anesthetized with ketamine/xylazine (80 and 10 mg/kg
body weight, respectively) and a cranial window pre-
pared. The dura was cut and reflected away to expose
the right MCA and a small piece of parafilm was posi-
tioned underneath the artery. Gelfoam soaked in a 10%
solution of 1,10-dioctadecyl-3,3,30,30-tetramethylindocar-
bocyanine perchlorate (DiI; Life Technologies) dissolved
in ethanol was placed on top of the artery after which
another piece of parafilm was placed on top of the gel-
foam. The skin was sutured and the animal was placed
on a heating pad during recovery. During recovery, 5 ml
of hydroxystilbamidine (Fluorogold, 10% solution in
DMSO; Life Technologies) was slowly administered
into the right nasal cavity of the rat to label trigeminal
innervation of the nasal epithelium. Animals were
allowed to recover for one week prior to inhalation
experiments. In addition, some of the animals received
an injection of DiI into the hindpaw footpad during
recovery to label neurons in the dorsal root ganglia.
Inhalation exposure
Rats were exposed to acrolein by mixing acrolein gas
(Air Liquide, Plumsteadville, PA) and room air to
obtain the desired concentration as described previous-
ly.20 The acrolein dosage (0.3 ppm) was chosen because
it produced minimal or no detectable harmful effects in
previous studies.20,23–25 In addition, it is equivalent to
the limit for short-term exposure recommended by the
National Institute of Occupational Safety and Health.
Separate inhalation chambers (Braintree Scientific, Inc;
5.5 L total volume) and tubing were used for acrolein
and control groups to avoid cross-contamination. The
flow rate was maintained at 1.5 L/min and temperature
and humidity were monitored in the chamber. Rats were
exposed to acrolein (0.33 0.03 ppm) (n¼ 34) 4 h per
day for four days while control animals were exposed to
room air with the same paradigm. Cumulative acrolein
exposure for each animal was determined with monitor-
ing badges placed in the chamber (Advanced Chemical
Sensors Inc, Boca Raton, FL). On day 5, approximately
24 h after the last inhalation exposure, tissue from
retrograde-labeled animals was harvested for laser dis-
section microscopy or laser Doppler flowmetry was con-
ducted as described below.
Infraorbital injection
The technique for trigeminal ganglion injections fol-
lowed those detailed by Neubert et al.26 Briefly, the
head of an anesthetized animal was stabilized in one
hand and the rostral portion of the zygomatic process
of the maxillary bone palpated. A sterile 25 gauge
20mm needle was then inserted medial to the zygomatic
process through the infraorbital foramen. Drugs dis-
solved in saline and 0.2% Trypan Blue solution (Sigma
# T8154) were then injected (7 ml) over 1 min using a
Hamilton syringe. The needle remained in the foramen
for 5 min and was then slowly removed. Trypan Blue
served as verification of successful drug injection into the
ganglia and animals in which the dye was not visible or
in which dye was observed outside the ganglion follow-
ing blood flow measurements were excluded from anal-
ysis. Injected drugs included carbenoxolone (Sigma
#C4790), CGRP8-37 (Tocris #1169), DL-TBOA (Tocris
#1223), D-APV (Tocris #0106), and A-317491 (Santa
Cruz #sc-300144). Saline and CGRP8-37 inactivated
with the reducing agent TCEP-HCL (Thermoscientific
#20490) were used as controls. Agents were injected
under anesthesia 2 h before blood flow measurements.
Laser Doppler flowmetry
Laser Doppler flowmetry was performed as previously
described between 10:00 and 15:00.18 Male rats were
anesthetized with ketamine/xylazine (80 and 10mg/kg
Zhang et al. 3
body weight, respectively), followed by additional doses
of ketamine/xylazine (40 and 5 mg/kg body weight) as
needed. Body temperature was maintained at 37C with
a homeothermic blanket. For the measurement of men-
ingeal blood flow, the skull was fixed in a stereotaxic
frame and a cranial window prepared with the dura
left intact.18 Dural blood flow was measured with a
laser Doppler flowmeter (TSI, MN). A needle-type
probe was placed over a large branch of the middle men-
ingeal artery (MMA), distant from visible cortical blood
vessels and the cranial window kept moist with synthetic
interstitial solution (SIF) consisting of 135 mM NaCl,
5mM KCl, 5 mM CaCl2, 1 mMMgCl2, 10 mM HEPES,
and 10 mM D-glucose (pH 7.3). Blood flow was sampled
at 1 Hz with a Digidata 1320 interface using Axoscope
software (Axon Instruments, CA).
Blood flow drug administration
To stimulate the nasal mucosa, 25 ml of the TRPV1 ago-
nist, capsaicin, or vehicle solution was applied over a
30-s period at a site 2 mm into the right nostril using a
Pipetman pipette.18,27 Stock solutions of the TRPV1
agonist, capsaicin (10 mM; Sigma), were dissolved
in ethanol and stored at 20C and then diluted to the
desired concentration with SIF prior to use. Submaximal
concentrations of capsaicin (30 nM) were used for test-
ing the effects of the glutamate reuptake blocker where
potentiation might be expected, whereas higher capsai-
cin doses were used when antagonists were being tested.
A 30-min stabilization period preceded all blood flow
measurements. Each animal in blood flow experiments
was given nasal saline as a vehicle control 15 min before
administering capsaicin. Saline produced less than 2%
change in blood flow on average consistent with our
previous published results (data not shown).8,18
Laser dissection microscopy
Brains were extracted after euthanasia and the underly-
ing right TG removed, snap frozen on dry ice and kept at
80C until use. In animals which received hindpaw
injections of DiI, ipsilateral L4-S1 dorsal root ganglia
were also harvested. Ganglia were subsequently cut
using a microtome at 12 mm sections and collected on
Lecia PPS membrane slides (Cat # 11505273). Laser
microdissection was performed using a Leica AS
LMD7000 system. Fluorescent cells were dissected
using a 20 objective and collected into the cap of a
500 mL microcentrifuge vial containing 50 mL TRIzol
(Life Technologies, Foster City, CA). A total of 75 DiI
or Fluorogold labeled cells per sample were cut and col-
lected respectively from each animal. The samples were
gently spun and transferred to a 1.5 ml vial containing
950 mL of TRIzol and stored at 80C.
RNA isolation and quantitative RT-PCR
RNA from homogenized TG tissue lysate (25–30 mg)
was isolated and purified using the RNeasy Mini Kit
(Qiagen, Valencia, CA) according to the manufacturer’s
instructions. Genomic DNA was removed from isolated
RNA with TURBO DNAse (Life Technologies) and
yield and purity were determined on a Nanodrop ND-
1000 Spectrophotometer (Thermoscientific, Franklin,
MA). A260/A280 ratios were between 2.0 and 2.2 for all
samples. For laser dissection samples, 1 mL of glycogen
(Roche) was added and mixed well before cells were
sheared with 10 passes through a 21-gauge needle to
shear genomic DNA. Total mRNA was extracted
according to the supplier’s manual. Single-stranded
cDNA was synthesized from 1 mg mRNA using reverse
transcriptase (Superscript II reverse transcriptase, Life
Technologies) and Oligo(dT)12–18 primers (Life
Technologies).
Quantitative PCR (qPCR) reactions were run in trip-
licate on an ABI PRISM 7900HT Sequence Detection
System (Life Technologies). The cDNA was amplified
for quantitative RT-PCR with SYBR Green PCR
Master mix (Life Technologies) and gene specific pri-
mers as listed here and in Supplemental Table 1. The
primers for amplification of rat TRPV1 (Trpv1, Ref
NM_031982.1) message were as follows: TRPV1 for-
ward (50-AGG ACC CAG GCA ACT GTG-30,
TM¼ 58C) and TRPV1 reverse (50-ATC CCT CAG
AAG GGG AAC C-30, TM¼ 56C). These primers
span exons 15 and 16, align with nucleotides 2456–
2474 and 2362–2379 and produce a 113 bp product.
The primers for amplification of rat TRPA1 (Trpa1,
Ref NM_207608.1) were as follows: TRPA1 forward
(50-GCC CCT GTC TCT GTA AAT AAC C-30,
TM¼ 55C) and TRPA1 reverse (50-CTT GTG TCG
CTG ATG TCT TG-30, TM¼ 54C). These primers
span exons 11 and 12, align with nucleotides 1276–
1297 and 1402–1421 and yield a 146 bp product. The
primers for b-actin (Actb, Ref NM_031144.2) were as
follows: b-Actin forward (50-CAC TTT CTA CAA
TGA GCT GCG-30, TM¼ 54C) and b-actin reverse
(50-CTG GAT GGC TAC GTA CAT GG-30,
TM¼ 55C). The primers span exons 4 and 5, align
with nucleotides 345–365 and 473–492 and yield a
148 bp product. A mixture of cDNA template, SYBR
Green Master mix and forward and reverse primers was
treated with uracil N-glycosylase (Life Technologies)
before undergoing the following protocol: 50C for 2
min, 95C for 10 min, then 45 cycles of 95C for 15 s,
60C for 1 min, followed by one cycle of 95C for 15 s,
60C for 15 s, and 95C for 15 s. The PCR products were
analyzed with ABI PRISM sequence detection software.
The specificity of these amplifications was verified by
melt curve analysis with detection of only a single
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peak. Reactions containing no reverse transcriptase or
no template were run as negative controls.
Real-time qPCR data were analyzed with the DDCT
method as described by Livak and Schmittgen.28
Transcript levels were compared in whole TG or nasal
or dural cell populations of room air (control) and acro-
lein exposed animals, values normalized to b-actin and
calibrated to control data using the DDCT method.
b-actin was used as a reference gene, and its level was
not altered across these experimental conditions. The
quantification cycle (Cq) was defined as the number of
cycles required to attain a fluorescence threshold of
0.2 units.
Data collection and statistics
For blood flow experiments, data were collected at 1 Hz.
Basal blood flow was determined as the mean flow rate
measured during a 4-min period prior to drug applica-
tion and the effects of test compounds were calculated
by comparing the peak response after drug or saline
administration to the basal blood flow. Changes
in blood flow were calculated relative to the basal
blood flow for each animal, averaged within treatment
groups, and expressed as percent changes. Comparison
of blood flow changes was performed using a two-tailed
Student’s t test with Welch’s correction for unequal var-
iances. qPCR results were calculated with the DDCT
method as described and presented as relative expression
levels.28 Data presentation and statistical analyses were
performed using GraphPad Prism software (GraphPad,
CA). Averaged data values are presented as means
 SEM. The significance level for all tests was set
at p< 0.05.
Results
Intraganglionic administration of neurotransmitter
modulators alters meningeal blood flow responses
to nasal irritant
Neuronal somata within sensory ganglia can communi-
cate with and modulate the activity of neighboring cells
via the local release of chemical mediators.2,3,6,7
Evidence from in vitro and in vivo studies suggest that
glutamate,11 CGRP,14 and ATP13 may act as neuro-
transmitters within sensory ganglia. Gap junctions and
satellite glia may also have important roles in chronic
trigeminal pain.15,17 To test whether these mediators
contribute to irritant-induced trigeminovascular
responses, we injected neurotransmitter modulators
into the TG via the infraorbital foramen. The effect of
local administration of modulators was assessed by mea-
suring meningeal blood flow changes after nasal admin-
istration of the TRPV1 agonist, capsaicin (Figure 1).
Injection of the glutamate reuptake inhibitor TBOA11
(1mM) significantly potentiated peak blood flow
response to 30 nM capsaicin (Figure 1(a)) compared to
saline only injection (169 49% (n¼ 6) vs. 16 5%
(n¼ 8), p¼ 0.0207). Furthermore, injection of the
N-Methyl-D-aspartate (NMDA) receptor antagonist
D-APV (10 mM) significantly reduced the peak blood
flow in response to nasal administration of 100 nM
Figure 1. Effects of neurotransmitter modulators on meningeal blood flow changes after trigeminal ganglion injection. (a) Ganglionic
injection of TBOA, a glutamate re-uptake inhibitor, potentiates meningeal blood flow response to nasal administration of 30 nM capsaicin.
(b) Effects of CGRP, NMDA, and P2X3 receptor antagonists and a gap junction inhibitor on meningeal blood flow response to nasal
administration of 100 nM capsaicin. Injection of CGRP8-37, D-AP5, A317491, or the gap junction inhibitor carbenoxolone, significantly
attenuated peak blood flow in response to 100 nM capsaicin compared to saline injection. In contrast, inactive CGRP8-37 had no effect on
blood flow response. Values are means SEM. Number of animals per group is indicated. *p< 0.05 compared to blood flow change in
saline-injected animals.
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capsaicin compared to saline only injection (Figure 1(b),
15 3% (n¼ 6) vs. 65 12% (n¼ 15), p¼ 0.0013).
Together, these observations are consistent with a role
for glutamate as an important neurotransmitter in the TG.
CGRP has a widely recognized role in migraine pain
pathways and has been a recent focus for new migraine
therapeutics.29 The CGRP antagonist, CGRP8-37, signifi-
cantly decreased meningeal blood flow in response to cap-
saicin compared to saline injections (19 6% (n¼ 7),
p¼ 0.0036) after local administration, whereas injection
of a chemically inactivated form of CGRP8-37 did not
alter blood flow responses to capsaicin compared to
saline injections (63 12% (n¼ 7), p¼ 0.5469). ATP
antagonists had similar inhibitory effects on blood flow
responses compared to saline. Intraganglionic injection of
the purinergic P2X3 receptor antagonist, A-317491
(60mM), significantly reduced peak blood flow in
response to 100 nm capsaicin (20 4% (n¼ 6),
p¼ 0.0033, compared to saline injections). Lastly, we
examined the effect of gap junction blockade.
Carbenoxolone16 (100 mM) injected into the TG signifi-
cantly reduced peak blood flow response in response to
capsaicin (17 2% (n¼ 7), p¼ 0.016). Taken together,
these results (Figure 1(b)) support the role of cross-talk
in the TG, specifically the influence of the neurotransmit-
ters glutamate, ATP, and CGRP and of gap junctions.
CGRP enhances the excitability of sensory
neuron soma
In the case of glutamate and ATP, it is well established
that sensory neuron soma express glutamate receptors
Figure 2. CGRP enhances the excitability of sensory neuron soma. (a) Voltage responses of a dissociated DRG neuron to ramp currents
under control conditions, 3 min in 100 nM CGRP, and following 5 min of washout. Traces are vertically displaced by 20 mV for visual clarity.
Note the ramp threshold (red dot) for each set of traces. A 0.5 nA step current preceded each ramp to monitor membrane resistance.
(b) Firing of a neuron is induced by 300 nM CGRP (gray bar) which is suppressed by the CGRP receptor antagonist, CGRP8-37 (black bars).
This neuron, as most observed, was capsaicin sensitive (red bar).
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and P2X receptors and that they are excitatory.11,30,31
However, it is less clear what responses, if any, CGRP,
a well-documented vasodilatory peptide, would elicit
from sensory neuron soma upon release. We have used
whole-cell recording methods to investigate what mem-
brane potential responses might be elicited by applica-
tion of CGRP to isolated sensory neuron soma. We
observed CGRP to be excitatory either through lowering
the threshold for eliciting action potentials (Figure 2(a))
or eliciting spontaneous firing that was reversed by the
receptor antagonist CGRP8-37 (Figure 2(b)). We current-
ly do not know the mechanism for the increased excit-
ability, but one group has reported a transient increase
in tetrodotoxin (TTX)-resistant sodium currents in
DRG neurons by CGRP.32 Nonetheless, this excitatory
response is consistent with a potential sensitizing/acti-
vating role for CGRP within sensory ganglia.
Laser capture dissection and qPCR of distinct nasal or
meningeal projecting neuron populations in the TG
In our previous studies, we demonstrated that acrolein
exposure sensitizes the trigeminovascular response to
subsequent nasal administration of TRPV1 or TRPA1
agonists,19,20 but the mechanism of this response is not
known. Immunocytochemistry revealed no differences in
cell numbers expressing either TRPV1 receptor or
CGRP in the whole TG, nor were differences detected
in mRNA levels of TRPV1 or TRPA1 receptors after
acrolein exposure.20 To identify mechanisms underlying
the sensitization observed after acrolein exposure,
we conducted additional qPCR studies of known signal-
ing molecules in migraine pathways. Interestingly, we
observed no differences in mRNA levels of CGRP, its
receptor subunit components RAMP1 and CLR, the
glutamate receptor GluN1, the purinergic receptor
P2X3, and the gap junction hemichannel Cx43 in whole
TG following acrolein or room air exposure
(Supplemental Figure 1). Since the relevant nasal-
meningeal pathway comprises only a small subset of tri-
geminal neurons, it might be that changes occurred in
one or both of these subsets and could not be detected in
whole TG owing to a poor signal/noise ratio. Thus, we
used two retrograde tracers combined with laser capture
dissection to isolate neurons specific to either nasal (FG)
or meningeal sensory afferents (DiI) (Figure 3). We
found the distribution of retrograde label in the TG
from the nasal epithelium and dura similar to our
previous findings8 with FG and DiI labeled neurons
prominent in the V1 and V2 subdivisions of the ganglia.
Furthermore, this labeling is consistent with other stud-
ies wherein nasal innervation of the TG33,34 or cerebral
vessels9,35 was traced. Examples of TG sections before
and after laser dissection to capture FG labeled cells
are depicted in Figure 3(a). After laser capture of these
distinct identified neurons, we compared message levels
in the two populations. Under control conditions
b-actin, TRPA1, or TRPV1 mRNA levels did not
differ between nasal and meningeal projecting neurons
(Figure 3(b)). CT values were 30.0 0.6 versus 29.8 0.9
for b-actin, 33.0 0.4 versus 32.6 0.6 for TRPV1, and
36.3 0.6 versus 34.4 0.7 for TRPA1 in meningeal
(n¼ 6 rats) and nasal (n¼ 5 rats) cells, respectively.
TRPA1 mRNA levels differ in nasal- and meningeal-
projecting neuron populations after acrolein exposure
We then compared message levels in dissected cell sam-
ples from both nasal and meningeal labeled populations
following inhalation pre-exposure of animals to either
acrolein or room air (Figure 4). Relative expression
levels of TRPV1 mRNA were not different when com-
paring acrolein-exposed animals to room air-exposed
animals in either the meningeal population (0.95 1.4
(n¼ 11) vs. 1.0 1.15 (n¼ 12)) or the nasal labeled pop-
ulation (0.78 1.26 (n¼ 13) vs. 1.0 0.93 (n¼ 14)). In
contrast, TRPA1 mRNA levels were significantly
increased in the meningeal cell population of acrolein-
exposed animals compared to room air-exposed animals
Figure 3. Laser dissection and mRNA expression levels following
retrograde labeling in the trigeminal ganglion in the absence of
acrolein exposure. (a) Representative image of TG section fol-
lowing retrograde labeling of nasal epithelium (Fluorogold; blue)
and middle meningeal artery (DiI; red) before (left) and after
(right) laser dissection capture. Labeled cells in the ganglion were
dissected and processed separately before qPCR. (b) CT levels of
b-actin, TRPA1 and TRPV1 mRNA were compared in meningeal
and nasal cell populations and did not differ in the absence of
acrolein. Values are means SEM. Number of animals per group is
indicated. Scale bar 50 um.
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(2.38 1.61 (n¼ 11) vs. 1.0 1.45 (n¼ 12), p< 0.05),
whereas no differences were observed in the nasal cell
population (0.67 1.45, (n¼ 13) vs. 1.0 1.64 (n¼ 14)).
No change in expression of CGRP or P2X3 mRNA was
observed in either nasal or meningeal labeled afferent
samples following acrolein exposure (Supplemental
Figure 2). The significant increase (greater than two-
fold) in TRPA1 mRNA observed in the meningeal cell
population may contribute to the mechanism for the
sensitized response of the trigeminovascular pathway
following acrolein exposure. While we cannot exclude
possible contributions of mRNA from adjacent non-
neuronal tissue obtained in the laser dissection, little
evidence suggests that TRP channels are expressed in
satellite glia surrounding the neuron soma.
Laser capture dissection and qPCR of dorsal root
ganglia neurons
To determine if the increased expression in TRPA1
mRNA is specific to sensory neurons in TG, we also
retrogradely labeled and dissected sensory neurons
from L4-S1 DRG following acrolein- or room air expo-
sure. Compared to room air-exposed animals, no differ-
ences in relative expression levels were detected in
acrolein-exposed animals (Figure 5) in mRNA message
levels of TRPA1 (0.92 1.13 (n¼ 7) vs. 1.0 1.18
(n¼ 8)), TRPV1 (1.03 0.89 (n¼ 7) vs. 1.0 0.78
(n¼ 8)), CGRP (0.92 1.14 (n¼ 7) vs. 1.0 0.80 (n¼ 8)),
or P2X3 (0.92 1.14 (n¼ 7) vs. 1.0 1.06 (n¼ 8)). As no
changes in mRNA were detected in DRG neurons, we con-
clude that the expression change of TRPA1 mRNA in sen-
sory neurons projecting to the meninges in the TG is
specific to that sensory pathway.
Discussion
Migraine is unique among primary headache syndromes
due to its association with odors and poor air quality.36
Although odorants and environmental irritants are rec-
ognized as specific triggers for migraine, little is known
about the etiology of this disorder. In addition, headache
Figure 4. Fold changes in expression levels of TRPV1 and TRPA1 mRNA in meningeal and nasal afferent populations of trigeminal ganglia
neurons following acrolein exposure. Acrolein exposure induced a significant increase in expression of TRPA1 mRNA in the meningeal
retrograde-labeled neurons compared with room air-exposed animals. No change in expression of TRPA1 mRNA was observed in nasal
epithelium labeled trigeminal neurons. Likewise, no change in TRPV1 mRNA was observed in either meningeal or nasal afferent samples
following acrolein exposure compared with room air-exposed animals. Each sample’s value is normalized to b-actin values using the DDCT
method and averaged across groups. Values are represented as mean SEM. Number of animals per group are indicated. *p< 0.05
compared to mRNA expression change in room air-exposed animals.
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is cited as one of the most common symptoms of the
acquired disorder, multiple chemical sensitivity, usually
provoked by chemical exposure. We previously reported
that TRPA1 agonists and environmental irritants such
as acrolein and formaldehyde acutely activate the trige-
minovascular system after nasal administration.8,18
More importantly, subacute exposure to the environ-
mental irritant, acrolein, induces long-lasting sensitiza-
tion of the migraine pain pathway.19,20 These studies
were undertaken to explore the underlying mechanism
by which the environmental irritant, acrolein, activates,
and sensitizes the trigeminovascular system.
The trigeminovascular system is comprised of the tri-
geminal sensory neurons which reside in the ganglion
and innervate the head, face, cerebral blood vessels,
and dura. Nociceptive information arising from cerebral
blood vessels during migraine is referred to the forehead.
Surprisingly, the mechanism of referred pain in migraine
is likely not due to a classic axon reflex as neurons inner-
vating the MCA do not project divergent collaterals to
the forehead.9,37 Instead the cells innervating the fore-
head “clump” around individual cells innervating the
MCA. This is comparable to our finding that trigeminal
cells innervating the nasal epithelium do not project
divergent collaterals with cells innervating the dura but
reside in close proximity within the ganglia.8 Thus,
the question arises—how does nasal administration
evoke changes in meningeal blood flow? We hypothesize
that intraganglionic transmission mediates this activa-
tion, and we utilized a local injection of the trigeminal
ganglion26 to block or modulate neurotransmission in
the ganglion while minimizing damage to brain struc-
tures involved in nociception. The neurotransmitters,
CGRP, glutamate, and ATP have each been implicated
in cell–cell communication in sensory ganglion. While
previous studies have demonstrated the expression of
excitatory glutamate receptors11,30,31 and ATP recep-
tors38 in sensory neurons, the role of CGRP has not
been as well-documented. We and others have verified
that sensory neurons express the CGRP coreceptors
CLR and RAMP1 (data not shown).39 Our data
(Figure 2) reveal that CGRP has an excitatory effect
on sensory neuron soma. The mechanism responsible
for the excitation is not clear but one group has reported
a transient increase in TTX-resistant sodium currents in
DRG neurons by CGRP.32 Our data (Figure 1) demon-
strate that injection of a CGRP antagonist into the
trigeminal ganglion attenuates blood flow changes pro-
viding further evidence that CGRP may be important in
intraganglionic transmission. Our data are consistent
with the finding of Ulrich-Lai et al.14 who reported
that the TRPV1 agonist, capsaicin, evokes release of
Figure 5. Fold changes in expression of TRPA1, TRPV1, CGRP, and P2X3 in retrograde-labeled dorsal root ganglion neurons following
acrolein exposure. Expression levels of mRNA do not change in sensory neurons of the dorsal root ganglion following acrolein exposure
compared with room air-exposed animals. Each sample’s value is normalized to b-actin values using the DDCT method and averaged across
groups. Values are represented as mean SEM. Number of animals per group are indicated.
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CGRP from trigeminal ganglion slices presumably from
the cell soma. Similarly, our data (Figure 1) demonstrate
that blocking reuptake of glutamate potentiates menin-
geal blood flow changes, while blocking NMDA recep-
tors inhibits blood flow changes. This is consistent with
the study of Laursen et al.11 who reported glutamate
release from satellite glia cells cultured from the trigem-
inal ganglion and that glutamate injection into trigemi-
nal ganglion increased electrical activity which was
potentiated by TBOA and blocked by APV. ATP is
also a candidate for signaling within sensory ganglion.
Our data (Figure 1) indicate that purinergic P2X3 recep-
tor antagonist attenuates trigeminovascular activation
after injection in trigeminal ganglion. This concurs
with the reports of Zhang et al.40 and Rozanski et al.13
which point to an important role for ATP in cell–cell
transmission. Several groups also implicate satellite glia
in an unusual form of cell–cell cross-talk.13,40 Evidence
has substantiated the putative role of satellite glia17 and
in particular gap junctions in craniofacial pain.16
We tested the role of gap junctions in acute nasal-
meningeal signaling. Carbenoxolone, a gap junction
blocker significantly reduced the change in meningeal
blood flow seen after nasal administration of capsaicin.
Likewise, blockade of gap junctions has attenuated pain
signaling in other models of pain.4,16 Overall these data
corroborate the theory that intraganglionic transmission
is important in the trigeminovascular system.
To gain a better understanding of the mechanism of
sensitization after acrolein exposure, we examined
mRNA levels of candidate signaling molecules in the
whole trigeminal ganglion20 and Supplemental Figure 1
in the absence and presence of acrolein exposure. Since
we observed no differences in whole ganglion mRNA
levels after acrolein, we isolated meningeal and nasal
cell populations to quantify important trigeminal signal-
ing molecules at a pathway-specific level. Our report
demonstrates the presence of several important signaling
molecules including TRPA1, TRPV1, CGRP, and ATP
receptors in both meningeal and nasal cell populations
(Figures 4 and 5 and Supplemental Material). Nasal tri-
geminal neurons have previously been shown to express
TRPV1 in mice38,41 and guinea pigs,42 ATP receptors in
rodents,38 and CGRP in rodents.34,43 Although TRPA1
has been described in nasal epithelium44,45 including
mast cells and macrophages,46 to our knowledge, this
is the first report of TRPA1 mRNA in trigeminal inner-
vation of nasal mucosa. Trigeminal neurons innervating
the cerebral blood vessels express TRPA1,35,47 TRPV1,35
CGRP,10,35 and glutamate receptor mRNA.48 We com-
pared mRNA levels of these signaling molecules in
selected cell populations in the absence or presence of
acrolein exposure and observed a significant and specific
increase in TRPA1 mRNA in trigeminal neurons inner-
vating the meninges. This change was not observed in
neurons innervating the nasal epithelium or in dorsal
root ganglia innervating the paw. While we have not
quantified changes at the TRPA1 protein level in the
selected cell populations, this observation points to a
selective mechanism mediating sensitivity changes in
the headache circuit. It has been previously suggested
that TRPA1 and TRPV1 contribute to the excitability
of dura afferents35 and thus may have a role in migraine
susceptibility. The upstream mediators which effect
changes in TRPA1 mRNA levels are not well-
understood, but TRPA1 is upregulated under inflamma-
tory conditions49–51 or by known migraine triggers such
as nitroglycerin.52 Other effectors may include endoge-
nous lipids, the most well-known of which is ananda-
mide, a TRPV1 and CB(1) receptor agonist53 and
other lipids recently identified as TRP agonists.54 In
addition to inducing trigeminal sensitization and chronic
migraine phenotypes in our animal model,19,20 acrolein
exposure induced changes in several endocannabinoids,
including anandamide, in trigeminal tissue.55 Indeed,
interactions between endocannabinoids and TRP chan-
nels are strongly implicated in pain53 and particularly
migraine.56 While additional studies are necessary to
understand the regulation of TRPA1 expression and
putative roles of endogenous lipids, both should be con-
sidered as viable targets for pain relief in migraine.
Taken together, these data implicate intraganglionic
transmission in acute signaling in the trigeminovascular
pathway via signaling molecules known to be important
in migraine. Herein, we also report the upregulation of
TRPA1 message in this pathway after environmental
irritant exposure, a putative mechanism of sensitization
in chronic migraine.
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